This study is testing a new way to deliver intermittent theta burst stimulation (iTBS) for women with postpartum depression. iTBS is a type of transcranial magnetic stimulation (TMS) that uses magnetic pulses to stimulate specific areas of the brain. The study is looking at whether a shorter, more intense treatment schedule (either 10 times a day for 6 days or 12 times a day for 5 days) is practical and well-tolerated. You may be able to join if you are a woman between 18 and 50 years old and have been diagnosed with postpartum depression within the last year. The study will be considered successful if most participants complete the treatment and can receive the full intended dose. The current status of this study is unclear.

Study design

This is an open-label study, meaning both you and the study team will know what treatment you are receiving. It aims to enroll 40 participants.

What's involved

You would receive iTBS treatment either 10 times a day for 6 days or 12 times a day for 5 days. You would also complete assessment instruments.

Compensation

Not stated in the trial record.

Follow-up

The primary goals of the study are measured at 7 days after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.